CME on ReachMD-logo

CME on ReachMD

ReachMD

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.
More Information

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Language:

English


Episodes

Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018

11/13/2018
More
CME credits: 0.50 Valid until: 13-11-2019 Claim your CME credit at https://reachmd.com/programs/cme/uncontrolled-moderate-severe-asthma-latest-data-floor-chest-2018/10484/ Not only do serious exacerbations interfere with a patient’s daily activities, but they also account for much of the morbidity and mortality associated with asthma, as well as at least half of asthma-related costs. That’s why clinicians need information about new research to optimize their management of patients with...

Duration:00:29:59

Establishing an In-Office Minimally Invasive Surgery Practice: Driving Better Patient and Practice Outcomes

11/7/2018
More
CME credits: 0.50 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/establishing-in-office-minimally-invasive-surgery-practice-driving-better-patient-practice-outcomes/10481/ Whenever the topic of establishing minimally invasive hysteroscopic surgery in the office setting comes up, many physicians ask why and how. Leveraging decades of professional experience, this activity answers those questions by reviewing the necessary training and staff requirements,...

Duration:00:29:59

Minimally Invasive Hysteroscopic Surgery: A “Start-Up Guide” for the Office Setting

11/7/2018
More
CME credits: 0.25 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/minimally-invasive-hysteroscopic-surgery-start-guide-office-setting/10480/ To help you and your patients realize the benefits of in-office versus hospital-based surgeries, this activity outlines how to obtain the necessary clinical training and hysteroscopic case experience, meet staffing and facility needs, and market and cultivate a patient base.

Duration:00:17:29

Guidelines, Risks, and the Evolution of Tissue Morcellation within the Ob/Gyn Office

11/7/2018
More
CME credits: 0.25 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/guidelines-risks-and-the-evolution-of-tissue-morcellation-within-the-obgyn-office/10479/ To help you ensure the safe and effective use of tissue morcellation during hysteroscopic and abdominal procedures, this activity will focus on the guidelines, evolutions in the procedure, and the risks versus benefits of adopting this technique.

Duration:00:14:59

Addressing Operative Challenges with Hysteroscopic Surgery

11/7/2018
More
CME credits: 0.25 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/addressing-operative-challenges-with-hysteroscopic-surgery/10478/ This activity will discuss approaches that enable physicians to perform hysteroscopic surgery more safely and effectively by focusing on best practices, overcoming operative difficulties, and the inclusion of pharmacologic agents that improve visualization, reduce vascularity, and lower the possibility of hyponatremia.

Duration:00:17:00

Diagnostic and Management Updates for Abnormal Uterine Bleeding

11/7/2018
More
CME credits: 0.50 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-and-management-updates-for-abnormal-uterine-bleeding/10477/ This activity will discuss the numerous elements that make up the updated diagnostic and treatment algorithm to manage abnormal uterine bleeding, including using a minimally invasive surgical approach, having a better understanding of the broad umbrella of bleeding that occurs outside of normal cyclic menstruation,...

Duration:00:22:59

Hysteroscopic Surgery & Fluid Management Strategies

11/7/2018
More
CME credits: 0.25 Valid until: 31-03-2020 Claim your CME credit at https://reachmd.com/programs/cme/hysteroscopic-surgery-fluid-management-strategies/10476/ This activity will discuss the most significant changes in both in-office and outpatient hysteroscopic procedures, especially those which have resulted in the need to reappraise the parameters of fluid absorption.

Duration:00:17:59

Dyspareunia: Best Practices in Counseling, Diagnosis, and Therapy

11/2/2018
More
CME credits: 0.50 Valid until: 02-11-2019 Claim your CME credit at https://reachmd.com/programs/cme/dyspareunia-best-practices-counseling-diagnosis-and-therapy/10461/ Vulvar vaginal atrophy (VVA) affects about half of the 64 million postmenopausal women in the U.S. VVA is the loss of estrogen stimulation on vaginal and vulvar tissue, resulting in atrophy of these tissues and these women may suffer from symptoms, which include dyspareunia - or painful sexual intercourse. With this,...

Duration:00:31:29

Hypoactive Sexual Desire Disorder: New Strategies for Patient Counseling, Diagnosis, and Management

11/2/2018
More
CME credits: 0.50 Valid until: 02-11-2019 Claim your CME credit at https://reachmd.com/programs/cme/hypoactive-sexual-desire-disorder-new-strategies-patient-counseling-diagnosis-and-management/10460/ Hypoactive sexual desire disorder, or HSDD, is the most common female sexual dysfunction with about 10% of premenopausal women in the US believed to have this condition. HSDD is consistently underdiagnosed and undermanaged due to the lack of adequate physician-patient communication on this...

Duration:00:30:59

How Improved Hepatitis B Vaccination Coverage Can Protect At-Risk Adults

11/1/2018
More
CME credits: 0.50 Valid until: 01-11-2019 Claim your CME credit at https://reachmd.com/cme/infectious-diseases/how-improved-hepatitis-b-vaccination-coverage-can-protect-at-risk-adults/10435/ Expert Interview is a 30-minute activity that offers healthcare professionals insights into the experiences of medical experts. During this concise, easy to digest thirty-minute segment, National Foundation for Infectious Diseases (NFID) Medical Director William Schaffner, MD, conducts an interview...

Duration:00:30:29

Quality Care in the Delivery Room: Can the Use of Fetal Fibronectin (fFN) Help Meet Quality Standards?

10/31/2018
More
CME credits: 0.25 Valid until: 31-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/quality-care-delivery-room-can-use-fetal-fibronectin-ffn-help-meet-quality-standards/10463/ Preterm birth not only causes steep medical costs, but it also has a significant impact on the child and family, resulting in both short-term and long-term complications like neurocognitive delays and growth impairments. This activity will explore the use of fetal fibronectin (fFN) as a marker for...

Duration:00:15:59

Addressing Endometriosis with Your Patients: Combining Individualized Treatment Options with Patient-Clinician Dialogue

10/31/2018
More
CME credits: 0.25 Valid until: 31-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/addressing-endometriosis-your-patients-combining-individualized-treatment-options-patient-clinician-/10470/ Endometriosis, defined as the presence of endometrial tissue outside of the uterus, is the third leading cause of gynecologic hospitalization in the US. Cyclical bleeding from these ectopic endometrial implants leads to the development of inflammation, scarring, and adhesions that...

Duration:00:16:29

Thrombocytopenia and New Pathways Forward

10/31/2018
More
CME credits: 0.25 Valid until: 31-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/thrombocytopenia-and-new-pathways-forward/10462/ Thrombocytopenia, or low platelet count, is the most frequent hematologic complication of chronic liver disease, and its impact can be devastating on patient care. Due to the risk of bleeding, patients with thrombocytopenia are blocked from receiving crucial invasive therapeutic and diagnostic procedures, which affects those with severe...

Duration:00:14:59

Molecular Profiling, Precision Medicine, and Targeted Therapies for the Treatment of ALK Positive NSCLC

10/30/2018
More
CME credits: 0.75 Valid until: 29-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/molecular-profiling-precision-medicine-targeted-therapies-for-the-treatment-of-alk-positive-nsclc/10348/ The discovery of predictive biomarkers, such as sensitizing epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) rearrangements, ROS1 rearrangements, and BRAF V600E mutations has led to an improvement in overall survival and progression-free survival in...

Duration:00:43:59

JAK Inhibition in Rheumatoid Arthritis

10/29/2018
More
CME credits: 0.25 Valid until: 29-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/jak-inhibition-in-rheumatoid-arthritis/10442/ This activity will provide foundational information for rheumatologists, focusing on changes to recently published guidelines and treatment algorithms that highlight the use of non-tumor necrosis factor (TNF) inhibitors in management strategies for rheumatoid arthritis.

Duration:00:18:59

JAK Inhibition in Inflammatory Bowel Disease

10/29/2018
More
CME credits: 0.25 Valid until: 29-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/jak-inhibition-in-inflammatory-bowel-disease/10441/ This activity will provide foundational information for gastroenterologists, highlighting recent guidelines and newly published data related to emerging management approaches in IBD, including JAK inhibitor therapy.

Duration:00:16:59

JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

10/29/2018
More
CME credits: 0.25 Valid until: 29-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/jak-stat-signaling-and-disease-pathogenesis-in-ra-and-ibd/10440/ With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.

Duration:00:18:59

Diabetic Macular Edema Treatment in the 21st Century

10/25/2018
More
CME credits: 0.25 Valid until: 25-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/diabetic-macular-edema-treatment-21st-century/10250/ This activity will discuss the DRCR Network’s treatment algorithm for diabetic macular edema (DME) as well as the treatment results obtained by using this algorithm. Also covered will be how to avoid under-treatment in the first year of therapy and over-treatment thereafter, the average number of injections that will be administered over...

Duration:00:14:59

Psoriatic Arthritis & Better Measuring Patient Response to Therapy

10/23/2018
More
CME credits: 0.25 Valid until: 23-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/psoriatic-arthritis-better-measuring-patient-response-to-therapy/10405/ When you hear PsA outcome measures, you may instantly think of physician-centered ones, such as assessing disease activity for inflammatory joint disease, skin manifestations, and extra-articular features. While these outcome measures are certainly important, they’re starting to be examined in light of new...

Duration:00:17:29

When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM

10/15/2018
More
CME credits: 0.50 Valid until: 14-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/when-insulin-isnt-enough-exploring-dual-sglt1-and-sglt2-inhibition-t1dm/10437/ This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician and patient perspectives on their use.

Duration:00:19:29